An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77731 · Cited by 632

Evaluation of nine commercial SARS-CoV-2 immunoassaysPreprint

Lassaunière, R., Frische, A., Harboe, Z. B., Nielsen, A. C. Y., Fomsgaard, A., Krogfelt, K. A., & Jørgensen, C. S. (2020) · medRxiv · doi:10.1101/2020.04.09.20056325 · Cited by 319

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015

Choe, P. G., Perera, R. A. P. M., Park, W. B., Song, K.-H., Bang, J. H., Kim, E. S., Kim, H. B., Ko, L. W. R., Park, S. W., Kim, N.-J., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2307.170310 · Cited by 227

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Bryant, J. E., Azman, A. S., Ferrari, M. J., Arnold, B. F., Boni, M. F., Boum, Y., Hayford, K. T., Luquero, F. J., Mina, M. J., Rodríguez-Barraquer, I., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc6347 · Cited by 142

Herd immunity is not a realistic exit strategy during a COVID-19 outbreakPreprint

Slot, E., Hogema, B. M., Reusken, C. B. E. M., Reimerink, J. H. J., Molier, M., Karregat, J. H. M., IJlst, J., Novotny, V. M. J., van Lier, R. A. W., & Zaaijer, H. L. (2020) · Research Square · doi:10.21203/rs.3.rs-25862/v1 · Cited by 55

SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022

Campman, S. L., Boyd, A. C., Schinkel, J., Coyer, L., Agyemang, C. O., Galenkamp, H., Koopman, A. D. M., Chilunga, F. P., Koopsen, J., Zwinderman, A. H., et al. (2025) · Epidemiology and Infection · doi:10.1017/s0950268825000056 · Cited by 2

Verificación del desempeño de la prueba rápida "AMP Rapid Test SARS-CoV-2 IgG/IgM- Cassettes"

Gil-Villa, D. M., Arias, J. C., Martínez-Muñoz, M. A., Zuluaga‐Vélez, A., Hoyos-Pulgarín, J. A., Martínez, J. W., Montoya, Á. M. G., Valencia-Buitrago, A. M., & Sánchez‐Duque, J. A. (2021) · Infectio · doi:10.22354/in.v25i3.942 · Cited by 2

Simultaneous detection of antibody responses to multiple SARS-CoV-2 antigens by a Western blot serological assay

Hsiao, C.-C., Chiang, Y.-W., Chao, T., Tsai, Z.-U., Wang, T.-X., Jiang, Y.-W., Hsu, H.-F., Lu, D.-C., Wang, J., Wang, A.-B., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12288-0 · Cited by 2

SARS-CoV-2 Infections, Vaccination, and Vaccine Effectiveness in Thailand, January 2021–January 2022: Results of a Cohort Study in Four Provinces

Nakphook, S., William, D., Prasert, K., Ditsungnoen, D., Lerdsamran, H., Puthavathana, P., Sirikhetkon, S., Chalom, K., Sawangpun, K., Iamsirithaworn, S., et al. (2023) · Outbreak Surveillance Investigation & Response (OSIR) Journal · doi:10.59096/osir.v16i4.264238 · Cited by 2

SARS-CoV-2 infection: diagnostic testing results occasionally require special attention

Riva, E., Sainaghi, P. P., Turriziani, O., Antonelli, G., & Patti, G. (2020) · Emerging Microbes and Infections · doi:10.1080/22221751.2020.1814165 · Cited by 2

Early diagnosis and population prevention of coronavirus disease 2019

Su, Y.-Y., Zhang, S.-Y., Li, T., & Xia, N. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000649 · Cited by 2

Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort

Mara, E., Breitsching, V., Schuster, T., & Pekar, T. (2021) · Clinical Immunology Communications · doi:10.1016/j.clicom.2021.08.002 · Cited by 2

Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies

Jung, B. K., Yoon, J. H., Bae, J., Kim, J., Park, M., Lee, S. Y., & Lim, C. S. (2021) · Diagnostics · doi:10.3390/diagnostics11122193 · Cited by 3

Role of Antibodies against SARS-COV-2 in the Detection of Corona Virus, its Transmissibility and Immunological Status Determination among Different Population in Babylon Province

Al-Saray, D. A., Al-Asady, F. M., & Tuhair, T. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9372 · Cited by 1

The Luciferase Immunoprecipitation System (LIPS) Targeting the Spike Protein of SARS-CoV-2 Is More Accurate than Nucleoprotein-Based LIPS and ELISAs for Mink Serology

Auer, A., Bortolami, A., Berguido, F. J., Bonfante, F., Terregino, C., Natale, A., Fincato, A., Colitti, B., Rosati, S., Lamien, C. E., et al. (2023) · Transboundary and Emerging Diseases · doi:10.1155/2023/1318901 · Cited by 1

The Significance and Implications of Nanotechnology in COVID-19

Rahman, M. M., Md., K., Roy, U. K., Shohan, S. M., Tasnim, J., Islam, M. J., Shila, M. S., Chakraborty, S., & Wahed, M. I. I. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00411 · Cited by 2

Anti-SARS-CoV-2 Neutralizing Responses in Various Populations: Use of a Rapid Surrogate Lateral Flow Assay and Correlations with Anti-RBD Antibody Levels

Gozlan, J., Baron, A., Boyd, A. C., Salmona, M., Fofana, D., Minier, M., Gabassi, A., Morand‐Joubert, L., Delaugerre, C., & Maylin, S. (2024) · Life · doi:10.3390/life14070791 · Cited by 1

Molecular and seroepidemiology of SARS-CoV-2 among influenza-like illness and severe Acute respiratory illness cases in selected health facilities in Ethiopia

Tayachew, A., Arimide, D. A., Shure, W., Teklu, D. S., Gebeyehu, A., Berkessa, T., Teka, G., Kebede, M., Wossen, M., Abte, M., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1714899 · Cited by 1

Advances in the Application of CRISPR/Cas Systems in Molecular Diagnostics

Haozhe, R., Shiyuan, L., Yiqing, Y., Pengfei, C., & Ke, W. (2026) · Synthetic biology and engineering · doi:10.70322/sbe.2026.10005 · Cited by 1

Direct Immunodetection of Global A‐to‐I RNA Editing Activity with a Chemiluminescent Bioassay

Knutson, S. D., Arthur, R. A., Johnston, H. R., & Heemstra, J. M. (2021) · Angewandte Chemie · doi:10.1002/ange.202102762 · Cited by 1

Estudio piloto: análisis y detección de anticuerpos IgM e IgG específicos contra el dominio de unión al receptor de la proteína de la espiga del SARS-CoV-2

Mayora, S. J., Martínez, W. Y., Guerrero, M., Belisario, I., Sanctis, J. B. D., & García, A. H. (2022) · Gaceta Médica de Caracas · doi:10.47307/gmc.2022.130.1.10 · Cited by 1

Methods employed in a 2021 population-based serosurvey in Somalia

Hossain, M. S., Ali, A. A., Clary, C. B., Cooley, G. M., Farid, M., Gerber, S., Hoff, N. A., Ibrahim, A., Mainou, B. A., Malik, S. M. M. R., et al. (2024) · Gates Open Research · doi:10.12688/gatesopenres.15270.1 · Cited by 1

Serological survey in a university community after the fourth wave of COVID-19 in Senegal

Thiam, F., Diouara, A. A. M., NDIAYE, C. S. C. A., Diouf, I., Kébé, K., Senghor, A., DJOUMOI, D., Mbaye, M. N., Diop, I., Sané, S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298509 · Cited by 1

Clinician guide to COVID-19 diagnostics

Iro, M. A., Umpleby, H., & Pelosi, E. (2021) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2020-321272 · Cited by 2

Optimal Selection of COVID-19 Serological Testing Kits

Ashankyty, I. (2020) · JORDI - Journal of Oral Diagnosis · doi:10.5935/2525-5711.20200022 · Cited by 1

Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19

Prakash, O., Solanki, B., Sheth, J. K., Shah, T., Kadam, M., Vyas, S., Shukla, A. A., Pethani, J., & Tiwari, H. (2021) · Cureus · doi:10.7759/cureus.17956 · Cited by 1

COMPARISON OF PERFORMANCE CHARACTERISTICS BETWEEN LATERAL FLOW, ELISAAND ELECTROCHEMILUMINESCENCE IMMUNOASSAYS FOR THE DETECTION OF SARS-COV-2 ANTIBODIES AMONG HEALTHCARE WORKERS

Shincy, M. R., Govindan, V., Sudhakar, H. H., Venkatesha, V. T., Padmapriya, K., & Ravikumar, K. L. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/0101617 · Cited by 1

SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran

Amanat, A., Lankarani, K. B., Honarvar, B., Asmarian, N., Shokripour, M., Rafiee, F., Ghadim, M. B. A., Izadi, F., Omidifar, N., & Dorraninejad, S. A. (2022) · Shiraz E-Medical Journal · doi:10.5812/semj-121681 · Cited by 1

Profiling of SARS‐CoV‐2 neutralizing antibody‐associated antigenic peptides signature using proteome microarray

Wu, M., Liu, J., Wang, X., Zhang, X., Liang, T., Chen, L., Huang, T., Li, Y., Zheng, C. J., Yang, Y., et al. (2023) · MedComm · doi:10.1002/mco2.361 · Cited by 1

Development and Evaluation of Two Rapid Indigenous IgG-ELISA immobilized with ACE-2 Binding Peptides for Detection Neutralizing Antibodies Against SARS-CoV-2Preprint

Sil, B. K., Adnan, N., Oishee, M. J., Ali, T., Jahan, N., Khandker, S. S., Kobatake, E., Mie, M., Khondoker, M. U., Haq, M. A., et al. (2020) · medRxiv · doi:10.1101/2020.12.19.20248535 · Cited by 1

Development of low-cost serological immunoassay to detect antiviral antibodies to Sars-Cov-2 Spike proteinPreprint

Peroni, L. A., Toscaro, J. M., Canateli, C., Lima, G. C., Pagliarone, A. C., Cardoso, E. C., Viana, R., Borges, J. B., Lin‐Wang, H. T., Abboud, C. S., et al. (2021) · medRxiv · doi:10.1101/2021.06.07.21258114 · Cited by 1

The Effect of SARS-CoV-2 Vaccination on Post-Acute COVID-19 Syndrome (PACS): A Prospective Cohort StudyPreprint

Wynberg, E., Han, A. X., Boyd, A. C., van Willigen, H. D. G., Verveen, A., Lebbink, R., van der Straten, K., Kootstra, N. A., van Gils, M. J., Russell, C. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4022243 · Cited by 1

Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical ValidationPreprint

Calvo-Lozano, O., Sierra, M., Soler, M., Estévez, M. ‐., Chiscano‐Camón, L., Ruiz-Sanmartín, A., Ruiz‐Rodríguez, J. C., Ferrer, R., González‐López, J. J., Esperalba, J., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14595654.v2 · Cited by 1

Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variantPreprint

Springer, D. N., Perkmann, T., Jani, C. M., Mucher, P., Prüger, K., Marculescu, R., Reuberger, E., Camp, J. V., Graninger, M., Borsodi, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1669740/v1 · Cited by 1

Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variantPreprint

Springer, D. N., Perkmann, T., Jani, C. M., Mucher, P., Prüger, K., Marculescu, R., Reuberger, E., Camp, J. V., Graninger, M., Borsodi, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1669740/v2 · Cited by 1

Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variantPreprint

Springer, D. N., Perkmann, T., Jani, C. M., Mucher, P., Prüger, K., Marculescu, R., Reuberger, E., Camp, J. V., Graninger, M., Borsodi, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1669740/v4 · Cited by 1

First Sero-Epidemiological Investigation of SARS-CoV-2 among Students and Staff of Polytechnic High School a Community of Cheikh Anta Diop University after the Fourth Wave of COVID-19 in SenegalPreprint

Thiam, F., Diouara, A. A. M., NDIAYE, C. S. C. A., Diouf, I., Kébé, K., Senghor, A., DJOUMOI, D., Mbaye, M. N., Diop, I., Sané, S., et al. (2023) · Preprints.org · doi:10.20944/preprints202311.1372.v1 · Cited by 1

Reply to Nagappa and Marimuthu

Zhao, J., Su, Y., Ge, S., Zhang, J., & Zhang, Z. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa714

Clinical Correlates of Early IgG Response in Patients with Mild COVID-19Preprint

Kessler, A., Kenig, A., Azmanov, H., Gelman, R., Hurvitz, N., Perets, I., Oiknine‐Djian, E., Bdolah‐Abram, T., Zelig, O., Rotstein, Z., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-56853/v1

Prospective serological evaluation of anti SARS-CoV-2 IgG and anti S1-RBD antibodies in a community outbreak

Carta, M., Bragagnolo, L., Tramarin, A., Cappelletti, A., Barzon, E., Forner, L., Meneghini, M. G., Tripodi, C., Gottardo, M., Lago, F. D., et al. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0127

Practicability of serological assays for upscaling COVID-19 laboratory testing in Africa

Abdullahi, I. N., Emeribe, A. U., Animasaun, O. S., Ajagbe, O., Nwofe, J. O., Ghamba, P. E., Umeozuru, C. M., Asiegbu, E. C., Tanko, W. N., Gadama, A. S., et al. (2021) · Journal of Global Health · doi:10.7189/jogh.11.03038

Longitudinal Evaluation of mRNA Vaccinated Subjects using a Quidel Multianalyte Point-of-Care SARS-CoV-2 IgG ImmunoassayPreprint

Chen, X., Agarwal, S., Hoelscher, S., Egan, R., Jaiswal, D., Stassinopoulos, A., Reed, R., McClure, J., & Kroll, W. (2021) · medRxiv · doi:10.1101/2021.05.06.21256544

Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native and B.1.351 SARS-CoV-2 spike proteinsPreprint

Jodaylami, M. H., Djaïleb, A., Ricard, P., Lavallée, É., Cellier-Goetghebeur, S., Coutu, J., Stuible, M., Gervais, C., Durocher, Y., Cayer, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-646031/v1

Long-Term Antibody Response and Vaccination Efficacy in Patients with COVID-19: A Single Center One-Year Prospective Study from the Czech Republic

Fajfr, M., Sleha, R., Janovská, S., Koblížek, V., Skála, M., Plíšek, S., Prášil, P., Smahel, P., & Boštík, P. (2022) · Viruses · doi:10.3390/v14030526

Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical ValidationPreprint

Calvo-Lozano, O., Sierra, M., Soler, M., Estévez, M. ‐., Chiscano‐Camón, L., Ruiz-Sanmartín, A., Ruiz‐Rodríguez, J. C., Ferrer, R., González‐López, J. J., Esperalba, J., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14595654

Rapid, Sensitive and High-Throughput Screening Method for Detection of SARS-Cov-2 Antibodies by Bio-Layer Interferometry

Lokireddy, S. R., Kunchala, S. R., Godavarthy, R. P., Kona, V. S. K., Avula, L., Mishra, R. K., & Nalam, M. R. (2021) · Archives of Clinical and Medical Case Reports · doi:10.26502/acmcr.96550433

Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variantPreprint

Springer, D. N., Perkmann, T., Jani, C. M., Mucher, P., Prüger, K., Marculescu, R., Reuberger, E., Camp, J. V., Graninger, M., Borsodi, C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1669740/v3

Serological response after anti-SARS-CoV-2 BNT162b2 vaccine in IBD patients on biological therapy: a monocentric case-control study

Montori, M., Martini, F., BLASIO, F. D., Buono, T., Quatraccioni, C., Guardati, P., CALZOLARI, M., ROSSI, C., Bendia, E., Menzo, S., et al. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03134-5

Association of Time-Lines of COVID-19 Seropositivity with Antibody Ratio Levels

Mushtaq, S., Din, N. U., Shah, A. H., Riaz, O., Azam, K., & Khan, S. W. (2022) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v72i3.7173 · Cited by 1

A Brief Survey on the Advances of COVID-19 Treatment: With a New Suggestion to Capture Coronavirus by Magnetic Nanoparticles

Taheri‐Ledari, R. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.16.002270

Rapid cassette test results in anti-SARS-CoV-2 antibody screening verification by electrochemiluminescence immunoassay method

Akman, N., Akıdağı, Z., Özmen, P., & Yalap, R. (2023) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2023.48265

Comparative analysis of SARS-CoV-2 detection methods using stool, blood, and nasopharyngeal swab samples

Oloo, M. A., Awandu, S. S., Onyango, B., Magwanga, R. O., Ochieng, A. O., Lidechi, S., Muok, E. M. O., Munga, S., & Estambale, B. B. A. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.46.21.39483

Study of the Immune Response of COVID-19 Patients in Kirkuk Province

Breesam, A. A., & Noraldeen, M. Y. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_159_22

Durability of SARS-CoV-2 IgG Antibodies: Insights from a Longitudinal Study, Puerto RicoPreprint

Madewell, Z. J., Graff, N., Lopez, V. K., Rodríguez, D. M., Wong, J. M., Maniatis, P., Medina, F. A., Muñoz, J. L., Briggs‐Hagen, M., Adams, L. E., et al. (2024) · medRxiv · doi:10.1101/2024.08.01.24311375

Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study

Bolijn, R., Spijkerman, A. M. W., Galenkamp, H., Blokstra, A., Coyer, L., Boyd, A. C., Prins, M., & Stronks, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311196

Neonatal SARS‐CoV‐2 mRNA Vaccination Efficacy Is Influenced by Maternal Antibodies: Correspondence

Daungsupawong, H., & Wiwanitkit, V. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70028

A bivalent mRNA vaccine against RSV infection in rodent models

Liu, J., Zhao, H., Wang, W., Yang, B., Zhang, N., Zhang, Y., Qian, J., Ma, Q., Lu, Y., Han, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1542592

Multilayer SPR Biosensor for Early Detection of SARS-CoV-2 Virus

Qureshi, F., Jamali, A.-A., Ren, X., Laghari, M. U. R., Chandio, M., Koondhar, M. A., & Anjum, M. R. (2025) · Plasmonics · doi:10.1007/s11468-025-02876-x

Comparison of NADAL COVID IgG/IgM rapid test and DiaSorin Liaison SARS-CoV-2 S1/S2 IgG assay across different blood sources and substrates

Dasari, H., Bourassa, C., Renaud, C., Tremblay, C. L., & Ducharme, F. M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03350-24

ESTIMATING THE INCIDENCE OF SARS-COV-2 INFECTIONS IN 2020 IN BELGIUM BY JOINTLY MODELLING SEROPREVALENCE, HOSPITALIZATION AND MORTALITY DATAPreprint

Braeye, T., Pauw, R. D., Geebelen, L., Abrams, S., Desombere, I., Hens, N., Hammami, N., Roelants, M., & Herzog, S. A. (2025) · medRxiv · doi:10.1101/2025.07.02.25330709

Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France

Galmiche, S., Pinaud, L., Tondeur, L., Pelleau, S., Attia, M., Castelain, S., Staropoli, I., Duru, C., Koffi, A. D., Fernandes‐Pellerin, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26851-y

Additional file 1 of Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19

Smit, W. L., van Tol, S., Haas, L. E. M., Limonard, G. J. M., Bossink, A. W. J., Reusken, C. B. E. M., Heron, M., & Thijsen, S. (2024) · Figshare · doi:10.6084/m9.figshare.26586705

Additional file 1 of Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up

Recanatini, C., GeurtsvanKessel, C. H., Pas, S. D., Broens, E. M., Maas, M. L., van Mansfeld, R., Mutsaers-van Oudheusden, A. J. G., van Rijen, M., Schippers, E. F., Stegeman, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26647209

Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 – January 2021, Belgium

Braeye, T., Pauw, R. D., Geebelen, L., Abrams, S. A., Desombere, I., Hens, N., Hammami, N., Roelants, M., Muylaert, A., & Herzog, S. A. (2026) · Archives of Public Health · doi:10.1186/s13690-026-01860-z

SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique

Sevene, E., Maculuve, S. A., Tchavana, C., Valá, A., Quimice, L. M., Macuácua, S., Carrilho, C., Gonzalez, R., Nhampossa, T., Menéndez, C., et al. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09266-z

Presence of post-COVID-19 condition in six ethnic groups in Amsterdam, the Netherlands: a retrospectively reconstructed time interval approach

Spronk, M., Boyd, A. C., Campman, S. L., Jongen, V. W., Galenkamp, H., Chilunga, F., Agyemang, C., Schinkel, J., Wynberg, E., Stronks, K., et al. (2026) · Epidemiology and Infection · doi:10.1017/s095026882610199x

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Nicholson, S. R., Karapanagiotidis, T., Khvorov, A., Douros, C., Mordant, F. L., Bond, K. A., Druce, J. D., Williamson, D. A., Purcell, D. F. J., Lewin, S. R., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab239 · Cited by 28

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test

Bal, A., Pozzetto, B., Trabaud, M., Escuret, V., Rabilloud, M., Langlois, C., Paul, A., Guibert, N., d’Aubarede, C., Massardier-Pilonchery, A., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa336 · Cited by 74

Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays

Xue, H., Haynesworth, K., Hempel, H., Kemp, T. J., & Pinto, L. A. (2026) · Vaccines · doi:10.3390/vaccines14050395

Comparison of different serological assays for SARS-CoV-2 in real life

Brochot, É., Demey, B., Handala, L., François, C., Duverlie, G., & Castelain, S. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104569 · Cited by 43

A Comparison of the Performance of SARS-CoV-2 Antibody Assays in Healthcare Workers with COVID-19.

Kerr, C., Dunne, J., Hughes, G., Cox, F., Healy, M., Holmes, P., O'Rourke, F., O'Brien, C., Coyne, D., Crowley, V., et al. (2021) · PubMed · Cited by 2